Elanco Animal Health Incorporated : Investor Overview
ELAN
Published on 05/06/2026 at 09:02 am EDT
Food and Companionship Enriching Life
Touching nearly every person, every day
annual revenue (2025)
Countries Served
U.S.
48%
52%
International
Pet Health Farm Animal
>$100M annual revenue
49% 51%
Note: Rankings represent market share based on Elanco estimate of global animal health market. Revenue percentages are based on 2025 and exclude revenue contribution from 4
contract manufacturing. #2 Global Farm Animal position is based on Cattle, Swine, Poultry
Delivered late-stage
innovation pipeline
Built high-capacity R&D engine
Refilled pipeline for next wave
Focused on Innovation Delivery
Positioned for Sustainable Growth
Integrated Bayer Animal Health and Kindred
Achieved global scale, portfolio mix, omnichannel and productivity
Scaled for Global Reach
Growth: Stronger portfolios and share of voice
Established independent animal health leader, reaching the world's animals
Built global systems
Built the Foundation
Innovation: Multiple blockbusters globalizing and progressing next wave
Cash: Elanco Ascend with a focus on cash and margins
2018-2020 2019-2021 2021-2024 2025 & Beyond
5
Driving Growth, Innovation and Cash
Jeff Simmons
CEO
Consistent Flow of Innovation
Fueling Pipeline & Portfolio
Elanco Ascend
Margin & Cash
Risk & Access
Ellen de Brabander
Research & Development
Tim Bettington
Center for Strategic Growth
Bob VanHimbergen
Chief Financial Officer
Shiv O'Neill
General Counsel
Customer & Portfolio Value Driving Growth
Reliable Supply & Productivity
Culture & Engagement
Jose Simas
U.S. Farm Animal
Ramiro Cabral
International
Bobby Modi
U.S. Pet Health
Grace McArdle
Dave Kinard
Human Resources
6
Manufacturing & Quality
Disclaimer
Elanco Animal Health Inc. published this content on May 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 06, 2026 at 13:01 UTC.